当前位置:首页 - 行情中心 - 宣泰医药(688247) - 财务分析 - 资产负债表

宣泰医药

(688247)

  

流通市值:31.46亿  总市值:31.46亿
流通股本:4.53亿   总股本:4.53亿

资产负债表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
流动资产:
  货币资金83,775,232.04155,401,842.6143,878,735.73407,111,314.29
  交易性金融资产730,252,773.97658,314,628.77633,461,272.6339,341,275.35
  应收票据及应收账款47,013,324.6951,027,906.9162,489,667.280,003,716.62
  其中:应收票据175,000125,00050,00050,000
        应收账款46,838,324.6950,902,906.9162,439,667.279,953,716.62
  预付款项16,081,691.8314,320,883.7618,262,612.2415,264,322.29
  其他应收款合计2,813,549.392,429,618.69,676,205.553,242,682.6
  存货93,344,519.9476,934,143.765,038,476.5972,546,096.3
  合同资产9,407,518.48,026,565.319,944,677.216,245,350.07
  其他流动资产10,268,874.3111,463,546.0712,557,897.2311,118,502.54
  流动资产合计992,957,484.57977,919,135.72955,309,544.35934,873,260.06
非流动资产:
  长期股权投资71,614,840.1866,200,289.3164,600,854.4364,269,297.57
  其他非流动金融资产20,000,00020,000,00020,000,00020,000,000
  固定资产324,866,579.43308,945,056.27304,102,132.92306,277,664.62
  在建工程30,636,747.0352,272,752.3258,126,729.5257,576,398.81
  使用权资产37,189.7353,128.195,312.8121,251.27
  无形资产10,985,975.3412,217,442.2213,318,083.1314,976,762.4
  商誉16,221,129.9716,221,129.9716,221,129.9716,221,129.97
  长期待摊费用223,103.4292,475.46374,106.24460,413.79
  递延所得税资产20,301,787.4818,471,808.518,457,295.2119,011,820.87
  其他非流动资产3,111,164.962,390,466.93,554,770.84,411,384.07
  非流动资产合计497,998,517.52497,064,549.14498,760,415.03503,226,123.37
  资产总计1,490,956,002.091,474,983,684.861,454,069,959.381,438,099,383.43
流动负债:
  应付票据及应付账款39,512,595.629,053,005.8726,219,826.3625,862,109.75
        应付账款39,512,595.629,053,005.8726,219,826.3625,862,109.75
  合同负债39,846,566.8136,164,222.5934,320,091.9729,912,649.06
  应付职工薪酬8,839,712.639,075,993.956,158,611.0910,684,758.92
  应交税费740,710.49915,342.412,824,931.752,969,182.83
  其他应付款合计22,601,849.3518,305,737.2215,050,231.1411,087,810.56
        应付股利6,735,058.37-1,761,047.971,761,047.97
  一年内到期的非流动负债38,666.5938,187.266,593.7422,550.86
  其他流动负债1,441,709.352,396,921.252,396,347.472,420,302.54
  流动负债合计113,021,810.8295,949,410.5586,976,633.5282,959,364.52
非流动负债:
  长期应付职工薪酬1,455,5721,237,172908,246908,246
  预计负债3,200,0002,719,790.311,573,016.141,573,016.14
  递延收益52,960,592.9454,050,550.0853,886,467.5358,428,381.12
  递延所得税负债2,141,775.482,179,653.532,213,049.292,248,686.2
  非流动负债合计59,757,940.4260,187,165.9258,580,778.9663,158,329.46
  负债合计172,779,751.24156,136,576.47145,557,412.48146,117,693.98
所有者权益(或股东权益):
  实收资本(或股本)453,340,000453,340,000453,340,000453,340,000
  资本公积516,296,081.26514,610,946.86512,908,073.11512,924,510.11
  减:库存股36,126,025.2636,126,025.2636,126,025.2636,126,025.26
  其他综合收益-53,305.86-53,618.02-36,904.97-20,861.17
  盈余公积34,182,632.6134,182,632.6134,182,632.6134,182,632.61
  未分配利润350,536,868.1352,893,172.2344,244,771.41327,681,433.16
  归属于母公司股东权益合计1,318,176,250.851,318,847,108.391,308,512,546.91,291,981,689.45
  股东权益合计1,318,176,250.851,318,847,108.391,308,512,546.91,291,981,689.45
  负债和股东权益合计1,490,956,002.091,474,983,684.861,454,069,959.381,438,099,383.43
公告日期2026-10-292026-08-282026-04-302026-04-30
审计意见(境内)标准无保留意见
TOP↑